FDA approved gilteritinib, a targeted drug for leukemia tested at UPenn
On Nov. 28, 2018, The U.S. Food and Drug Administration (FDA) announced it had approved the first ever…
On Nov. 28, 2018, The U.S. Food and Drug Administration (FDA) announced it had approved the first ever…
On Nov. 27, 2018, the Canadian Cancer Trials Group announced the IND.234 clinical trial, the first of its…
On Nov. 20, 2018, the Abramson Cancer Center joined the National Comprehensive Cancer Networkï¾® (NCCN) as its 28th…
On Nov. 15, 2018, Pascal Biosciences announced the peer reviewed publication of their licensed cannabinoid-derived drug program for…
On Nov. 13, 2018, the Mayo Clinic announced a gift of $200 million from Jay Alix, noted philanthropist…
On Nov. 2, 2018, the Immunization Practices Advisory Committee (ACIP) published updated recommendations on use of hepatitis A…
On Nov. 2, 2018, AcelRx pharmaceutical’s DSUVIA was approved by U.S. Food and Drug Administration (FDA). DSUVIA is…
On Nov. 1, 2018, the Earth BioGenome Project (EBP) was launched, a global effort to sequence the genetic…
On Nov. 1, 2018, City of Hope, and its affiliate, Translational Genomics Research Institute (TGen), announced a letter…
On Oct. 30, 2018, Pascal Biosciences announced the Company had entered into an exclusive license agreement with the…
On Oct. 25, 2018, The Foundation for the National Institutes of Health, Biomarkers Consortium and the Critical Path…
On Oct. 25, 2018, the American Dental Association adopted a policy to support the use and administration of…
On Oct. 24, 2018, the U.S. Food and Drug Administration (FDA) announced it had granted approval of Xofluza…
On Oct. 22, 2018, the National Cancer Institute awarded a $10.7 million five year grant to Abramson Cancer…
On Oct. 22, 2018, the Siteman Cancer Center announced a second proton therapy system that would incorporate pencil-beam…
On Oct. 18, 2018, an international team of researchers reported that a surge in Lassa fever cases in…
On Oct. 16, 2018, Discovery Life Sciences expanded by merging with Conversant Bio, Folio Bio, and Phylogeny to…
On Nov. 9, 2918, the U.S. Centers for Disease Control and Prevention (CDC) reported an estimated 47.4 million…
On Oct. 5, 2018, the FDA announced it had approved a supplemental application for Gardasil 9 (Human Papillomavirus…
On Oct. 3, 2018, the Nobel Foundation announced that Frances H. Arnold had won a share of the…
On Oct. 2, 2018, Martin Health System and Cleveland Clinic signed a definitive agreement resulting in Martin Health…
On Oct. 1, 2018, James P. Allison, a native of Alice, Texas, son of a country doctor, and…
On Sept. 27, 2018, St.ï¾ Jude Children’s Hospital and the World Health Organization announced a five-year collaboration to transform…
On Sept. 27, 2018, CEPI (the Coalition for Epidemic Preparedness Innovations) announced a collaboration with The Jenner Institute…
On Sept. 25, 2018, the Cancer Prevention and Research Institute of Texas (CPRIT) announced the formation of the…
On Sept. 13, 2018, the Genome 10K (G10K) announced the launch of the international Vertebrate Genomes Project (VGP),…
On Sept. 7, 2018, Oregon Health & Science University (OHSU) announced the official completion of the Knight Cancer…
On Aug. 29, 2018, the Cancer Prevention and Research Institute of Texas (CPRIT) announced it would invest up…
On Aug. 24, 2018, Emory Universityï¾’s Alzheimer’s Disease Research Center was renamed the Goizueta Alzheimer’s Disease Research Center,…
On Jul. 19, 2018, scientists at HHMI announced detailed imaging of the entire brain of an adult female…